HC Wainwright Lowers ProPhase Labs (NASDAQ:PRPH) Price Target to $14.00
ProPhase Labs (NASDAQ:PRPH – Get Rating) had its price objective reduced by research analysts at HC Wainwright from $16.00 to $14.00 in a research report issued on Monday, The Fly reports. HC Wainwright’s target price would suggest a potential upside of 89.45% from the stock’s current price. A number of other brokerages also recently weighed […]